Status:
UNKNOWN
Gastro-oesophageal Reflux and NeuroDisability (Cerebral Palsy) in CHILDren
Lead Sponsor:
Poole Hospital NHS Foundation Trust
Collaborating Sponsors:
British Society of Paediatric Gastroenterology, Hepatology and Nutrition
Conditions:
Cerebral Palsy
GORD
Eligibility:
All Genders
2-16 years
Brief Summary
This study assesses the content validity of the PGSQ for parents/carer of children with cerebral palsy and GORD, including features such as readability, face validity and acceptability for completion....
Detailed Description
Gastro-oesophageal reflux disease (GORD) is a common condition, where acid from the stomach leaks up into the oesophagus (food pipe) causing highly unpleasant symptoms and sometimes needing hospital a...
Eligibility Criteria
Inclusion
- Parents or carers of children with cerebral palsy (GMFCS level III-V) with symptoms of GORD or on treatment for presumed GORD, aged between 2-16 years.
Exclusion
- Children whose parent/carer are not able to support their participation in the study in the opinion of the investigator (e.g. language/communication issue, health, burden).
Key Trial Info
Start Date :
January 22 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04293107
Start Date
January 22 2021
End Date
March 1 2024
Last Update
November 18 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Poole Hospital NHSFT
Poole, Dorset, United Kingdom, BH15 2JB
2
Poole Hospital
Poole, Dorset, United Kingdom, BH15 2JB